Profile | GDS4284 / 226733_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 381.64 | 60 |
GSM687648 | Patient 402 control | 1527.47 | 80 |
GSM687653 | Patient 403 control | 750.65 | 70 |
GSM687658 | Patient 404 control | 1262.23 | 77 |
GSM687663 | Patient 411 control | 960.073 | 73 |
GSM687668 | Patient 422 control | 849.779 | 72 |
GSM687673 | Patient 424 control | 841.311 | 71 |
GSM687678 | Patient 425 control | 188.917 | 46 |
GSM687683 | Patient 427 control | 1082.05 | 75 |
GSM687688 | Patient 428 control | 864.971 | 72 |
GSM687695 | Patient 441 control | 889.813 | 73 |
GSM687699 | Patient 443 control | 1270.86 | 78 |
GSM687704 | Patient 444 control | 779.737 | 70 |
GSM687707 | Patient 448 control | 1298.88 | 78 |
GSM687712 | Patient 449 control | 1401.39 | 79 |
GSM687719 | Patient 450 control | 2111.62 | 85 |
GSM687724 | Patient 451 control | 639.781 | 67 |
GSM687728 | Patient 452 control | 638.19 | 68 |
GSM687646 | Patient 401 treated 24h | 466.024 | 62 |
GSM687649 | Patient 402 treated 24h | 1745.33 | 82 |
GSM687665 | Patient 411 treated 24h | 1174.08 | 76 |
GSM687651 | Patient 402 treated 4 weeks | 1524.23 | 80 |
GSM687667 | Patient 411 treated 4 weeks | 1308.1 | 78 |
GSM687670 | Patient 422 treated 24h | 1083.2 | 75 |
GSM687671 | Patient 422 treated 4 weeks | 1102.52 | 75 |
GSM687654 | Patient 403 treated 24h | 604.646 | 67 |
GSM687675 | Patient 424 treated 24h | 858.46 | 72 |
GSM687685 | Patient 427 treated 24h | 1006.75 | 74 |
GSM687656 | Patient 403 treated 4 weeks | 941.538 | 73 |
GSM687677 | Patient 424 treated 4 weeks | 958.092 | 73 |
GSM687687 | Patient 427 treated 4 weeks | 1104.7 | 75 |
GSM687692 | Patient 428 treated 4h | 1010.22 | 74 |
GSM687716 | Patient 449 treated 4h | 954.458 | 74 |
GSM687722 | Patient 450 treated 4h | 1269.51 | 78 |
GSM687680 | Patient 425 treated 24h | 213.305 | 49 |
GSM687690 | Patient 428 treated 24h | 819.388 | 71 |
GSM687700 | Patient 443 treated 24h | 1065.13 | 74 |
GSM687705 | Patient 444 treated 24h | 683.532 | 69 |
GSM687714 | Patient 449 treated 24h | 1313.78 | 78 |
GSM687721 | Patient 450 treated 24h | 1272.96 | 78 |
GSM687682 | Patient 425 treated 4 weeks | 166.498 | 46 |
GSM687694 | Patient 428 treated 4 weeks | 987.634 | 73 |
GSM687702 | Patient 443 treated 4 weeks | 920.649 | 72 |
GSM687718 | Patient 449 treated 4 weeks | 1291.29 | 78 |
GSM687723 | Patient 450 treated 4 weeks | 1949.58 | 84 |
GSM687661 | Patient 404 treated 4h | 1273.96 | 77 |
GSM687710 | Patient 448 treated 4h | 1465.86 | 80 |
GSM687726 | Patient 451 treated 4h | 459.656 | 61 |
GSM687730 | Patient 452 treated 4h | 527.967 | 57 |
GSM687660 | Patient 404 treated 24h | 3997.64 | 92 |
GSM687697 | Patient 441 treated 24h | 955.611 | 74 |
GSM687709 | Patient 448 treated 24h | 1224.91 | 77 |
GSM687725 | Patient 451 treated 24h | 413.051 | 59 |
GSM687729 | Patient 452 treated 24h | 1450.54 | 81 |
GSM687727 | Patient 451 treated 4 weeks | 442.791 | 61 |
GSM687731 | Patient 452 treated 4 weeks | 605.779 | 66 |